Atwood & Palmer’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.73K Hold
35
﹤0.01% 385
2026
Q1
$10.3K Hold
35
﹤0.01% 375
2025
Q4
$9.56K Hold
35
﹤0.01% 379
2025
Q3
$9.46K Hold
35
﹤0.01% 389
2025
Q2
$9.65K Hold
35
﹤0.01% 392
2025
Q1
$9.29K Hold
35
﹤0.01% 335
2024
Q4
$8.13K Hold
35
﹤0.01% 356
2024
Q3
$7.72K Hold
35
﹤0.01% 355
2024
Q2
$6.88K Hold
35
﹤0.01% 353
2024
Q1
$7.54K Hold
35
﹤0.01% 326
2023
Q4
$7.37K Hold
35
﹤0.01% 331
2023
Q3
$7.01K Hold
35
﹤0.01% 322
2023
Q2
$6.49K Hold
35
﹤0.01% 334
2023
Q1
$6.7K Hold
35
﹤0.01% 317
2022
Q4
$5.89K Hold
35
﹤0.01% 342
2022
Q3
$6K Hold
35
﹤0.01% 324
2022
Q2
$7K Hold
35
﹤0.01% 342
2022
Q1
$8K Hold
35
﹤0.01% 378
2021
Q4
$8K Buy
+35
New +$7.7K ﹤0.01% 384
2017
Q1
Sell
-54
Closed -$6K 301
2016
Q4
$6K Hold
54
﹤0.01% 282
2016
Q3
$6K Buy
+54
New +$5.64K ﹤0.01% 276

Other funds holding CME

Atwood & Palmer's CME Position: Q2 2026 in Review

Atwood & Palmer held its CME Group (CME) position steady in Q2 2026 at 35 shares worth $7.73K. The position accounts for ﹤0.01% of the portfolio, ranked #385.

Atwood & Palmer first reported a position in CME in Q3 2016 and has held it in 21 quarters since. The position peaked at $10.3K in Q1 2026. 439 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Atwood & Palmer held 35 shares of CME Group worth $7.73K as of Q2 2026.
  • Atwood & Palmer left its CME Group share count unchanged in Q2 2026.
  • CME Group made up ﹤0.01% of Atwood & Palmer's portfolio in Q2 2026, its #385 holding.
  • Atwood & Palmer first reported a position in CME Group in Q3 2016 and has held it in 21 quarters since.
  • Atwood & Palmer's CME Group position peaked at $10.3K in Q1 2026.
  • 439 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Atwood & Palmer's 13F filing for Q2 2026, filed 8 Jul 2026.